|
 |
Cancer > Adjuvant
The following information is about Adjuvant.
Adjuvant Defined
Serving to aid or contribute; involving the use of, or functioning as, a medical adjuvant (the action of a certain bacteria).
This definition is in context to Cancer. See more contextual defintions for Adjuvant.
Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery
Published August 27, 2008, 3:12 pm, News-Medical-Net
Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After ...
Published August 27, 2008, 4:00 am, PR Newswire via Yahoo! Finance
Novartis announced today that Gleevec® tablets* has been granted priority review status by the US Food and Drug Administration as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors .
New Trial To Evaluate Nexavar® As Adjuvant Therapy In Liver Cancer
Published August 26, 2008, 6:15 am, Medical News Today
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. announced the start of a Phase III study with Nexavar® (sorafenib) tablets in liver cancer. The randomized, double-blind, placebo-controlled study is evaluating Nexavar as an adjuvant therapy for patients with hepatocellular carcinoma (HCC), or primary liver cancer.
Bayer And Onyx Begin Enrollment In STORM Trial Studying Nexavar As Adjuvant Therapy For Patients With Liver Cancer
Published August 22, 2008, 5:14 am, Medical News Today
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced the companies have begun enrolling patients in the STORM Sorafenib as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma trial.
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Published August 21, 2008, 5:00 am, PR Newswire via Yahoo! Finance
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in the STORM Sorafenib as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma trial.
Are you looking for additional Cancer > Adjuvant news? Try our new "Adjuvant News Focus" area.
Off-site Adjuvant Links, User Submitted
The following links have been collected through user bookmark submission in the Adjuvant category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Sun Jul 20
Wed Jul 2
- Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials -- Dahabreh et al. 13 (6): 620 -- The Oncologist: just a recent summary indicating that adjuvant treatment with herceptin helps HER2+ patients, no evaluation of HER2-
Tue May 6
Mon Apr 21
- EBBC: Aromatase Inhibitors Do Not Increase Cardiovascular Risks: In postmenopausal women with breast cancer, adjuvant treatment with aromatase inhibitors does not raise the risk for cardiovascular events. That is good news for patients.
Sun Mar 23
Thu Feb 7
- Novel Molecules Developed at UB Can Boost Vaccine Potency - UB NewsCenter: UB School of Medicine and Biomedical Sciences, developed and patented the LT-IIa and LT-IIb enterotoxins and their respective mutant proteins as new mucosal adjuvants, or "boosters ," that can enhance the potency of existing and future vaccines.
Sun Dec 9
- ScienceDirect - Critical Reviews in Oncology/Hemat ology : Breast cancer in the elderly: the role of adjuvant radiation therapy
- ScienceDirect - The Lancet : Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer
Fri Nov 30
Tue Oct 30
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Adjuvant. If you would like to find related tags we recommend Tag Patterns > Adjuvant
Off-site Adjuvant Research Links
If you still need additional information on Adjuvant then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Cancer Topics
Everything you need to know about Cancer
Cancer
If you know the Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.